Kabra Drugs Ltd
Kabra Drugs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Kabra Drugs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Kabra Drugs Ltd Share Price Chart
KABRADRUGS at 10 Jul 2026 05:15 PM Pharmaceuticals
21.70 -0.04(-0.18%)
Lowest Today 21.51
Highest Today 22.69
Today's Open 22.69
Prev. Close 21.74
52 Week High 35.52
52 Week Low 10.56
Kabra Drugs Ltd Fundamentals
Traded Volume: 38,265
Market Cap(Cr): 51.45
Avg Traded Price 21.93
1 Year return -0.78%
Upper Circuit 22.7
Lower Circuit 21.5
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) 8.30
EPS TTM NaN
Book value/Share NaN
Dividend Yield 1Y 0.00%
Kabra Drugs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Kabra Drugs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Kabra Drugs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y -0.78%
YTD 0.00%
Kabra Drugs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Kabra Drugs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Kabra Drugs Ltd Technical Details
Kabra Drugs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 21
Support 2 20
Support 3 18
Pivot Point : 22
Resistance 1 23
Resistance 2 24
Resistance 3 25
Kabra Drugs Ltd Corporate Actions
Kabra Drugs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Kabra Drugs Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by KABRADRUGS
Bonus
No Bonus has been declared by KABRADRUGS
Splits
No Split has been declared by KABRADRUGS
Others
Rights No Rights has been declared by KABRADRUGS
Kabra Drugs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Kabra Drugs Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Kabra Drugs Ltd's relative performance and valuation against major competitors.
Stock Name Vasundhara Rasayans Ltd ₹174.90 (+0.52%) M. Cap (Cr) 0.56 1 Yr Return (%) -16.62% P/E (TTM) 9.54 PB Ratio 1.36
Stock Name Biofil Chemicals & Pharmaceuticals Ltd ₹34.06 (-0.03%) M. Cap (Cr) 0.55 1 Yr Return (%) -26.55% P/E (TTM) 19.90 PB Ratio 2.57
Stock Name Bacil Pharma Ltd ₹38.50 (+0.37%) M. Cap (Cr) 0.55 1 Yr Return (%) +2.45% P/E (TTM) 41.14 PB Ratio 2.19
Stock Name Kabra Drugs Ltd ₹21.70 (-0.18%) M. Cap (Cr) 0.51 1 Yr Return (%) -0.78% P/E (TTM) 10.36 PB Ratio 1.74
Stock Name Vivimed Labs Ltd ₹5.53 (+2.22%) M. Cap (Cr) 0.46 1 Yr Return (%) -79.21% P/E (TTM) -1.28 PB Ratio -0.61
Stock Name Vista Pharmaceuticals Ltd ₹7.28 (+0.69%) M. Cap (Cr) 0.45 1 Yr Return (%) -35.58% P/E (TTM) -3.72 PB Ratio 1.23
Stock Name Shelter Pharma Ltd ₹27.40 (+6.41%) M. Cap (Cr) 0.46 1 Yr Return (%) -37.16% P/E (TTM) 5.11 PB Ratio 0.63
Kabra Drugs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Kabra Drugs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -9.47 Mar 2025 -4.71 Mar 2024 -0.21 Mar 2023 -0.35 Mar 2022 -0.13
PARTICULARS Investing Activities Mar 2026 -1.36 Mar 2025 -0.05 Mar 2024 0.00 Mar 2023 0.00 Mar 2022 0.00
PARTICULARS Financing Activities Mar 2026 0.12 Mar 2025 23.39 Mar 2024 2.88 Mar 2023 0.36 Mar 2022 0.13
PARTICULARS Net Cash Flow Mar 2026 -10.72 Mar 2025 18.63 Mar 2024 2.67 Mar 2023 0.00 Mar 2022 -0.01
Kabra Drugs Ltd Shareholding Pattern
This shows the ownership breakdown of Kabra Drugs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Kabra Drugs Ltd
Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. The Company has 500+ products across India. The Company was incorporated with a mission to enrich the lives through pharmaceutical solutions which are innovative, high-quality and accessible to every family it serves. The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel. In India there are very few manufacturers who are manufacturing the said products. The company is the sole manufacturer of antimicrobial hand wash gel and other disinfectant products in India. The company is also a registered supplier to the Ministry of Defence.Kabra Drugs are known to meet the diverse medical needs of patients in Emerging Markets in an innovative, socially responsible and commercially viable manner. Their products are manufactured at state of the art ultra modern plants with latest equipments backed by professional technocrats. The key strength comes from the development of new formulated speciality products, addressing critical therapeutic needs.Due to scarcity of working capital funds, the Company is not able to perform any business activities. To make the Company operational, the Board is making its best effort to implement the cost reduction measures to the extent feasible. Several cost cutting measures have been undertaken by the Company.
Whole Time Director & CFO
B V Anatha Kumar
Registered office 270 Shastri Market Indore, , Indore, Madhya Pradesh, 452007
FAX :
Background
Incorporation Year 1989
Face Value ₹10.00
Market Lot 1
FAQs on Kabra Drugs Ltd
How to buy Kabra Drugs Ltd shares?
To buy Kabra Drugs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Kabra Drugs Ltd?
The company has a market capitalization of ₹51.45.
What is the PE & PB ratio of Kabra Drugs Ltd?
PE is N/A and PB is N/A.
What is the Kabra Drugs Ltd dividend for 2025–26?
For the 2025–26 financial year, Kabra Drugs Ltd declared a final dividend of null% per share.